Annular elastolytic giant-cell granuloma: Difference between revisions
No edit summary Tag: Manual revert |
CSV import |
||
| Line 1: | Line 1: | ||
{{ | {{Short description|A rare skin condition characterized by annular lesions}} | ||
'''Annular elastolytic giant-cell granuloma''' (AEGCG) is a rare [[dermatological]] condition that presents with distinctive annular (ring-shaped) lesions on the skin. It is characterized by the presence of [[giant cells]] and the destruction of [[elastic fibers]] in the [[dermis]]. | |||
==Clinical Presentation== | |||
AEGCG typically manifests as annular plaques that are slightly raised and have a central area of clearing. These lesions are often found on sun-exposed areas of the skin, such as the [[face]], [[neck]], and [[arms]]. The lesions may vary in color from skin-colored to red or brown and can range in size from a few millimeters to several centimeters in diameter. | |||
==Pathophysiology== | |||
The exact cause of AEGCG is not well understood, but it is believed to involve an abnormal immune response that leads to the formation of [[granulomas]] and the destruction of elastic fibers in the skin. The presence of [[giant cells]] is a hallmark of the condition, and these cells are thought to play a role in the degradation of elastic tissue. | |||
==Histopathology== | |||
Histological examination of skin biopsies from affected areas reveals the presence of granulomatous inflammation with multinucleated giant cells. There is a notable loss of elastic fibers in the dermis, which can be demonstrated using special stains such as [[Verhoeff-Van Gieson stain]]. The granulomas are typically non-caseating and are composed of histiocytes and giant cells. | |||
}} | |||
'''Annular elastolytic giant-cell granuloma''' ( | |||
==Diagnosis== | ==Diagnosis== | ||
The diagnosis of AEGCG is primarily clinical, supported by histopathological findings from a skin biopsy. Differential diagnoses include other granulomatous skin conditions such as [[granuloma annulare]], [[sarcoidosis]], and [[necrobiosis lipoidica]]. | |||
== | ==Treatment== | ||
There is no standard treatment for AEGCG, and management is often symptomatic. Options may include topical or intralesional [[corticosteroids]], [[antimalarials]] such as [[hydroxychloroquine]], and [[immunosuppressive]] agents. Sun protection is recommended to prevent exacerbation of lesions. | |||
==Prognosis== | |||
The prognosis for AEGCG is generally good, as the condition is benign and does not lead to systemic complications. However, the lesions can be persistent and may cause cosmetic concerns for patients. | |||
==Related Pages== | |||
* [[Granuloma annulare]] | |||
* [[Sarcoidosis]] | |||
* [[Necrobiosis lipoidica]] | |||
* [[Dermatology]] | |||
[[Category:Dermatology]] | |||
[[Category:Granulomatous diseases]] | |||
Revision as of 19:23, 22 March 2025
A rare skin condition characterized by annular lesions
Annular elastolytic giant-cell granuloma (AEGCG) is a rare dermatological condition that presents with distinctive annular (ring-shaped) lesions on the skin. It is characterized by the presence of giant cells and the destruction of elastic fibers in the dermis.
Clinical Presentation
AEGCG typically manifests as annular plaques that are slightly raised and have a central area of clearing. These lesions are often found on sun-exposed areas of the skin, such as the face, neck, and arms. The lesions may vary in color from skin-colored to red or brown and can range in size from a few millimeters to several centimeters in diameter.
Pathophysiology
The exact cause of AEGCG is not well understood, but it is believed to involve an abnormal immune response that leads to the formation of granulomas and the destruction of elastic fibers in the skin. The presence of giant cells is a hallmark of the condition, and these cells are thought to play a role in the degradation of elastic tissue.
Histopathology
Histological examination of skin biopsies from affected areas reveals the presence of granulomatous inflammation with multinucleated giant cells. There is a notable loss of elastic fibers in the dermis, which can be demonstrated using special stains such as Verhoeff-Van Gieson stain. The granulomas are typically non-caseating and are composed of histiocytes and giant cells.
Diagnosis
The diagnosis of AEGCG is primarily clinical, supported by histopathological findings from a skin biopsy. Differential diagnoses include other granulomatous skin conditions such as granuloma annulare, sarcoidosis, and necrobiosis lipoidica.
Treatment
There is no standard treatment for AEGCG, and management is often symptomatic. Options may include topical or intralesional corticosteroids, antimalarials such as hydroxychloroquine, and immunosuppressive agents. Sun protection is recommended to prevent exacerbation of lesions.
Prognosis
The prognosis for AEGCG is generally good, as the condition is benign and does not lead to systemic complications. However, the lesions can be persistent and may cause cosmetic concerns for patients.
